Prescription vaginal spray gel offers a new option for the prevention and management of HPV-related cervical lesions, supporting cervical mucosal recovery, vaginal microbiota restoration and HPV clearance.
Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH’s launch of Colpofix®. The vaginal spray gel medical device is indicated for the prevention and treatment of cervical lesions caused by HPV.4
HPV is one of the most common viral infections worldwide, with one in 10 women in Singapore affected by the infection.1 A ‘wait and see’ approach is adopted as most cases clear naturally within one to two years, but when HPV persists, it can lead to cervical cell changes that require medical follow-up and monitoring.2 For many women, a ‘wait and see’ approach can mean living with uncertainty between appointments, unsure what the result means and what happens next and this period can feel like a long wait. Research shows that an abnormal result can also increase psychological stress.3 Women deserve healthcare solutions developed with their needs and experiences in mind.
Colpofix® gives healthcare professionals and women an additional option during this stage. It acts locally on the cervico-vaginal mucosa and helps control the physiological conditions of the transformation zone.
Read Full Article At Source
